| 000 | 01485cam a2200349Ii 4500 | ||
|---|---|---|---|
| 001 | 9781439892800 | ||
| 008 | 180706s20152015fluad ob 001 0 eng d | ||
| 020 |
_a9781439892800 _q(e-book : PDF) |
||
| 020 |
_z9781138749207 _q(paperback) |
||
| 020 |
_z9781439892794 _q(hardback) |
||
| 024 | 7 |
_a10.1201/9781351228800 _2doi |
|
| 035 | _a(OCoLC)897882563 | ||
| 040 |
_aFlBoTFG _cFlBoTFG _erda |
||
| 050 | 4 |
_aRA566.27 _b.N36 2015 |
|
| 082 | 0 | 4 |
_a615.902 _bN186 |
| 245 | 0 | 0 |
_aNanoparticles in the lung : _benvironmental exposure and drug delivery / _cedited by Akira Tsuda, Harvard University, Cambridge Massachusetts, USA, Peter Gehr, University of Bern, Switzerland. |
| 264 | 1 |
_aBoca Raton, FL : _bCRC Press : _bTaylor & Francis Group, _c2015. |
|
| 264 | 4 | _c©2015 | |
| 300 | _a1 online resource | ||
| 336 |
_atext _2rdacontent |
||
| 337 |
_acomputer _2rdamedia |
||
| 338 |
_aonline resource _2rdacarrier |
||
| 505 | 0 | _asection 1. Gas phase -- section 2. Airway/alveolar surface -- section 3. Crossing epithelial cells -- section 4. Translocation -- section 5. Drug delivery to the respiratory tract -- section 6. Special issues. | |
| 650 | 0 |
_aHealth risk assessment. _915983 |
|
| 650 | 0 |
_aLungs. _915984 |
|
| 650 | 0 |
_aNanoparticles. _97280 |
|
| 700 | 1 |
_aGehr, Peter, _eeditor. _915985 |
|
| 700 | 1 |
_aTsuda, Akira, _eeditor. _915986 |
|
| 776 | 0 | 8 |
_iPrint version: _z9781439892794 |
| 856 | 4 | 0 |
_uhttps://www.taylorfrancis.com/books/9781439892800 _zClick here to view. |
| 942 | _cEBK | ||
| 999 |
_c71155 _d71155 |
||